- Home
- CHKP vs TEVA Comparison
CHKP vs TEVA Comparison
Compare CHKP & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHKP | TEVA |
|---|---|---|
| Founded | 1993 | 1901 |
| Country | Israel | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6B | 30.2B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | CHKP | TEVA |
|---|---|---|
| Price | $192.22 | $28.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 24 | 8 |
| Target Price | ★ $230.95 | $27.00 |
| AVG Volume (30 Days) | 958.3K | ★ 11.4M |
| Earning Date | 10-28-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.68 | N/A |
| EPS | ★ 9.12 | 0.62 |
| Revenue | $2,684,200,000.00 | ★ $16,776,000,000.00 |
| Revenue This Year | $8.42 | $4.74 |
| Revenue Next Year | $6.01 | $0.48 |
| P/E Ratio | ★ $21.17 | $46.12 |
| Revenue Growth | ★ 6.31 | 0.02 |
| 52 Week Low | $178.64 | $12.47 |
| 52 Week High | $234.36 | $28.68 |
Technical Indicators
Market Signals| Indicator | CHKP | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 51.24 | 80.93 |
| Support Level | $180.72 | $24.01 |
| Resistance Level | $188.00 | $26.96 |
| Average True Range (ATR) | 5.63 | 0.68 |
| MACD | 0.72 | 0.19 |
| Stochastic Oscillator | 63.24 | 94.65 |
Price Performance
Historical ComparisonAbout CHKP Check Point Software Technologies Ltd.
Check Point Software Technologies is a pure-play cybersecurity vendor. The company offers solutions for network, endpoint, cloud, and mobile security in addition to security management. Check Point, a software specialist, sells to enterprises, businesses, and consumers. Around 50% of revenue is generated in Europe, the Middle East, and Africa, 40% from the Americas, and 10% from the Asia-Pacific region. The firm, based in Tel Aviv, Israel, was founded in 1993 and has about 5,000 employees.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.